Watch CBS News

Immunotherapy trial for rectal cancer offers hope for future

A small immunotherapy trial for a certain type of rectal cancer reports a 100% success rate. Dr. Jon LaPook explains how it's designed to work, and how it could be used as a model to treat other cancers.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.